Jacqueline Elizabeth Shea is COO at INOVIO PHARMACEUTICALS, INC. (INO). They have made 4 open-market trades across 1 company since 2021, most recently 2026-05-20.
CIK 0001771498
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INO | 111,021 | $110K |
Shares reported on the most recent Form 4, priced at the 2026-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INO | SELL | 2021-06-09 | 2021-06-11 | $10.01 | $771K | -4.6% | -10.4% | -7.8% |
| INO | SELL · 10b5-1 | 2021-03-26 | 2021-03-26 | $8.97 | $42K | -2.4% | -22.9% | -1.4% |
| INO | SELL | 2021-03-12 | 2021-03-12 | $10.06 | $340K | -15.8% | -22.8% | -14.2% |
| INO | SELL | 2021-02-01 | 2021-02-03 | $15.05 | $763K | -5.5% | -37.0% | -55.2% |
| INO | SELL | 2021-01-27 | 2021-01-29 | $12.03 | $1.1M | -5.7% | -15.7% | -49.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.